KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLoans - NetLoans - NetLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesReal Estate - NetReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthpeak Properties (DOC) Cash & Equivalents (2016 - 2026)

Healthpeak Properties has reported Cash & Equivalents over the past 17 years, most recently at $467.5 million for Q4 2025.

  • Quarterly Cash & Equivalents rose 290.14% to $467.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $467.5 million through Dec 2025, up 290.14% year-over-year, with the annual reading at $467.5 million for FY2025, 290.14% up from the prior year.
  • Cash & Equivalents was $467.5 million for Q4 2025 at Healthpeak Properties, up from $91.0 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $467.5 million in Q4 2025 and troughed at $34.0 million in Q1 2021.
  • The 5-year median for Cash & Equivalents is $99.3 million (2021), against an average of $120.4 million.
  • Year-over-year, Cash & Equivalents tumbled 95.26% in 2021 and then skyrocketed 290.14% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $158.3 million in 2021, then plummeted by 54.49% to $72.0 million in 2022, then surged by 63.31% to $117.6 million in 2023, then rose by 1.86% to $119.8 million in 2024, then skyrocketed by 290.14% to $467.5 million in 2025.
  • Per Business Quant, the three most recent readings for DOC's Cash & Equivalents are $467.5 million (Q4 2025), $91.0 million (Q3 2025), and $89.4 million (Q2 2025).